Page last updated: 2024-11-04

sulfadiazine and Optic Atrophy

sulfadiazine has been researched along with Optic Atrophy in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Optic Atrophy: Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions (see OPTIC ATROPHIES, HEREDITARY) are relatively common causes of this condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perrotta, S1
Nobili, B1
Grassia, C1
Sebastiani, A1
Parmeggiani, F1
Costagliola, C1

Other Studies

1 other study available for sulfadiazine and Optic Atrophy

ArticleYear
Bilateral neuroretinitis in a 6-year-old boy with acquired toxoplasmosis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2003, Volume: 121, Issue:10

    Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Child; Drug Therapy, Combination; Enzyme-Linke

2003